A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

Clinical trial NCT06428409 · RECRUITING

Trial details

NCT number: NCT06428409
Sponsor: Merck Sharp & Dohme LLC
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Pancreatic Ductal Adenocarcinoma Biliary Tract Cancer

Start date: 2024-06-20
Primary completion: 2029-10-16
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.